Our top pick for
Rand Capital Corporation is an asset management business based in the US. Rand Capital Corporation shares (RAND) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||USD$7.7313 - USD$21.9999|
|50-day moving average||USD$16.1864|
|200-day moving average||USD$13.1333|
|Wall St. target price||N/A|
|Dividend yield||USD$5.32 (34.43%)|
|Earnings per share (TTM)||USD$1.345|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Rand Capital Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Rand Capital Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Rand Capital Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Rand Capital Corporation shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Rand Capital Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$1.3 million.
The EBITDA is a measure of a Rand Capital Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$3 million|
|Operating margin TTM||42.01%|
|Gross profit TTM||USD$2.7 million|
|Return on assets TTM||1.59%|
|Return on equity TTM||6.69%|
|Market capitalisation||USD$39.9 million|
TTM: trailing 12 months
There are currently 1,558 Rand Capital Corporation shares held short by investors – that's known as Rand Capital Corporation's "short interest". This figure is 70.6% down from 5,297 last month.
There are a few different ways that this level of interest in shorting Rand Capital Corporation shares can be evaluated.
Rand Capital Corporation's "short interest ratio" (SIR) is the quantity of Rand Capital Corporation shares currently shorted divided by the average quantity of Rand Capital Corporation shares traded daily (recently around 11128.571428571). Rand Capital Corporation's SIR currently stands at 0.14. In other words for every 100,000 Rand Capital Corporation shares traded daily on the market, roughly 140 shares are currently held short.
However Rand Capital Corporation's short interest can also be evaluated against the total number of Rand Capital Corporation shares, or, against the total number of tradable Rand Capital Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Rand Capital Corporation's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Rand Capital Corporation shares in existence, roughly 0 shares are currently held short) or 0.0018% of the tradable shares (for every 100,000 tradable Rand Capital Corporation shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Rand Capital Corporation.
Find out more about how you can short Rand Capital Corporation stock.
Dividend payout ratio: 3934.22% of net profits
Recently Rand Capital Corporation has paid out, on average, around 3934.22% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 34.43% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Rand Capital Corporation shareholders could enjoy a 34.43% return on their shares, in the form of dividend payments. In Rand Capital Corporation's case, that would currently equate to about $5.32 per share.
Rand Capital Corporation's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Rand Capital Corporation's most recent dividend payout was on 19 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 December 2020 (the "ex-dividend date").
Rand Capital Corporation's shares were split on a 1:9 basis on 22 May 2020. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Rand Capital Corporation shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Rand Capital Corporation shares which in turn could have impacted Rand Capital Corporation's share price.
Over the last 12 months, Rand Capital Corporation's shares have ranged in value from as little as $7.7313 up to $21.9999. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rand Capital Corporation's is 0.2914. This would suggest that Rand Capital Corporation's shares are less volatile than average (for this exchange).
Rand Capital Corporation is a business development company and regulated investment company specializing in private equity investments. The firm prefers to make investments through equity or debt instruments in lower middle market and in small to medium-sized privately held companies. It generally lends to more mature companies. The firm does not prefer to invest in real estate sector. It invests in companies that are engaged in the exploitation of new or unique products, technologies, or services. The firm invests in healthcare, consumer products, manufacturing, software, and professional services. It seeks to invest in companies based in the Western and Upstate New York region and its surrounding states with focus on Buffalo and Niagara region. The firm may invest in region within three to five hour drives from Western New York including Canada. It typically invests between $0.5 million and $1.5 million and the total investment in rounds is between $1 million and $5 million. The firm seeks to invest up to maximum of $3 million total per company as part of follow-on investments. It invest in startups and companies having annual revenue up to $10 million. It invest companies having EBITDA up to $5 million. The firm Follow-on investment(s) up to a targeted maximum of $2 million to $3 million total per company. The firm frequently participate three investment round. The firm seeks to be a lead investor in companies within its geographical area and participates in syndicate/co-invest with other investors outside it. It prefers to invest in businesses that are unique or possess proprietary right. The firm prefers to be a minority investor and seeks to take a Board seat in its portfolio companies. It typically holds its investments for a period of five to seven years. Rand Capital Corporation was founded in 1969 and is based in Buffalo, New York.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.